Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04522544 |
Title | Durvalumab (MEDI4736) and Tremelimumab in Combination With Either Y-90 SIRT or TACE for Intermediate Stage HCC With Pick-the-winner Design |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | DEU |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Universitätsklinikum Bonn | RECRUITING | Bonn | 53127 | Germany | Details | |
Universitätsklinikum Essen | RECRUITING | Essen | 45147 | Germany | Details | |
Universitätsklinikum Freiburg | RECRUITING | Freiburg | 79106 | Germany | Details | |
Medizinische Hochschule Hannover | RECRUITING | Hannover | 30625 | Germany | Details | |
Universitätsklinikum Jena | RECRUITING | Jena | 07747 | Germany | Details | |
Universitätsklinikum Köln | RECRUITING | Köln | 50937 | Germany | Details | |
Universtitätsklinikum Schleswig-Holstein | RECRUITING | Lübeck | 23538 | Germany | Details | |
Klinikum rechts der Isar der Technischen Universität München | RECRUITING | München | 81675 | Germany | Details | |
München Klinik Bogenhausen | RECRUITING | München | 81925 | Germany | Details |